Cargando…
Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611881/ https://www.ncbi.nlm.nih.gov/pubmed/37452871 http://dx.doi.org/10.1007/s00259-023-06335-9 |
_version_ | 1785128582922633216 |
---|---|
author | Opalinska, Marta Lezaic, Luka Decristoforo, Clemens Kolenc, Petra Mikolajczak, Renata Studen, Andrej Simoncic, Urban Virgolini, Irene Trofimiuk-Muldner, Malgorzata Garnuszek, Piotr Rangger, Christine Fani, Melpomeni Glowa, Boguslaw Skorkiewicz, Konrad Hubalewska-Dydejczyk, Alicja |
author_facet | Opalinska, Marta Lezaic, Luka Decristoforo, Clemens Kolenc, Petra Mikolajczak, Renata Studen, Andrej Simoncic, Urban Virgolini, Irene Trofimiuk-Muldner, Malgorzata Garnuszek, Piotr Rangger, Christine Fani, Melpomeni Glowa, Boguslaw Skorkiewicz, Konrad Hubalewska-Dydejczyk, Alicja |
author_sort | Opalinska, Marta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10611881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-106118812023-10-29 Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor Opalinska, Marta Lezaic, Luka Decristoforo, Clemens Kolenc, Petra Mikolajczak, Renata Studen, Andrej Simoncic, Urban Virgolini, Irene Trofimiuk-Muldner, Malgorzata Garnuszek, Piotr Rangger, Christine Fani, Melpomeni Glowa, Boguslaw Skorkiewicz, Konrad Hubalewska-Dydejczyk, Alicja Eur J Nucl Med Mol Imaging Image of the Month Springer Berlin Heidelberg 2023-07-15 2023 /pmc/articles/PMC10611881/ /pubmed/37452871 http://dx.doi.org/10.1007/s00259-023-06335-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Image of the Month Opalinska, Marta Lezaic, Luka Decristoforo, Clemens Kolenc, Petra Mikolajczak, Renata Studen, Andrej Simoncic, Urban Virgolini, Irene Trofimiuk-Muldner, Malgorzata Garnuszek, Piotr Rangger, Christine Fani, Melpomeni Glowa, Boguslaw Skorkiewicz, Konrad Hubalewska-Dydejczyk, Alicja Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title | Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title_full | Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title_fullStr | Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title_full_unstemmed | Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title_short | Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor |
title_sort | comparison of 99mtc radiolabeled somatostatin antagonist with [(68) ga]ga-dota-tate in a patient with advanced neuroendocrine tumor |
topic | Image of the Month |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611881/ https://www.ncbi.nlm.nih.gov/pubmed/37452871 http://dx.doi.org/10.1007/s00259-023-06335-9 |
work_keys_str_mv | AT opalinskamarta comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT lezaicluka comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT decristoforoclemens comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT kolencpetra comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT mikolajczakrenata comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT studenandrej comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT simoncicurban comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT virgoliniirene comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT trofimiukmuldnermalgorzata comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT garnuszekpiotr comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT ranggerchristine comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT fanimelpomeni comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT glowaboguslaw comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT skorkiewiczkonrad comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor AT hubalewskadydejczykalicja comparisonof99mtcradiolabeledsomatostatinantagonistwith68gagadotatateinapatientwithadvancedneuroendocrinetumor |